The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 1968, 100: 292-301.
Copyright © 1968 by The American Association of Immunologists, Inc.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chedid, L.
Right arrow Articles by Boyer, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chedid, L.
Right arrow Articles by Boyer, F.

A Proposed Mechanism for Natural Immunity to Enterobacterial Pathogens

Louis Chedid1, Monique Parant1, Francine Parant1 and Fernand Boyer

Department of Experimental Chemotherapy, Institut Pasteur, Paris, France

Abstract

The bactericidal effect of normal mouse serum, generally ascribed to natural "O" antibodies, can be removed by absorption with rough microorganisms. Passive hemagglutination tests disclose the presence of thermolabile, non-agglutinating "R" antibodies in normal mouse serum; titers in germ-free animals are much lower. Horse hyperimmune serum against rough S. typhimurium protects mice against infection with unrelated virulent smooth K. pneumoniae. Provided the Klebsiellae are preincubated in normal mouse serum bactericidal activity can also be demonstrated in vitro. This activity does not require the presence of complement and can be removed either by the same Klebsiella strain or by rough strains of Salmonellae but not by the smooth strain of Salmonellae from which these mutants originate. Although these effects would most easily be accounted for by specific antibodies it is also possible that they are instead attributable to a serum protein capable of charge interaction with rough antigens. In any event these findings, together with previous observations concerning degradation of somatic antigen and phenotypic modification of Klebsiellae recovered from endotoxin-treated mice, have led to the development of a new concept of natural immunity to Enterobacteriaceae. In this hypothesis, enzymatic factors capable of attacking cell wall components unmask R antigenic sites common to many bacterial strains and species. Thereafter the presence of a few types of "R" antibodies or of serum factors reacting with rough antigens have the capability of coping, like masterkeys, with a very wide range of infections due to serologically unrelated organisms.

Footnotes

1 Centre National de la Recherche Scientifique.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Hellman, J. D. Roberts Jr., M. M. Tehan, J. E. Allaire, and H. S. Warren
Bacterial Peptidoglycan-associated Lipoprotein Is Released into the Bloodstream in Gram-negative Sepsis and Causes Inflammation and Death in Mice
J. Biol. Chem., April 12, 2002; 277(16): 14274 - 14280.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
E. Th. Rietschel and J.-M. Cavaillon
Endotoxin and anti-endotoxin The contribution of the schools of Koch and Pasteur: Life, milestone-experiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris)
Innate Immunity, April 1, 2002; 8(2): 71 - 82.
[PDF]

Home page
 Innate ImmunityHome page
J. Hellman and H. Shaw Warren
Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis
Innate Immunity, February 1, 2001; 7(1): 69 - 72.
[Abstract] [PDF]

Home page
 Infect. Immun.Home page
J. Hellman, P. M. Loiselle, M. M. Tehan, J. E. Allaire, L. A. Boyle, J. T. Kurnick, D. M. Andrews, K. Sik Kim, and H. S. Warren
Outer Membrane Protein A, Peptidoglycan-Associated Lipoprotein, and Murein Lipoprotein Are Released by Escherichia coli Bacteria into Serum
Infect. Immun., May 1, 2000; 68(5): 2566 - 2572.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
J. Hellman and H. S. Warren
Antibodies against bacterial membrane proteins
Innate Immunity, August 1, 1999; 5(4): 213 - 215.
[Abstract] [PDF]

Home page
 Infect. Immun.Home page
N. A. Nnalue
All Accessible Epitopes in the Salmonella Lipopolysaccharide Core Are Associated with Branch Residues
Infect. Immun., February 1, 1999; 67(2): 998 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. A. Nnalue
alpha -GlcNAc-1right-arrow2-alpha -Glc, the Salmonella Homologue of a Conserved Lipopolysaccharide Motif in the Enterobacteriaceae, Elicits Broadly Cross-Reactive Antibodies
Infect. Immun., September 1, 1998; 66(9): 4389 - 4396.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
S.E. Greisman and C.A. Johnston
Review: Evidence against the hypothesis that antibodies to the inner core of lipopolysaccharides in antisera raised by immunization with enterobacterial deep-rough mutants confer broad-spectrum protection during Gram-negative bacterial sepsis
Innate Immunity, April 1, 1997; 4(2): 123 - 153.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
P.H. Lagrange, H.S. Blanchard, and A. Felten
Review: Bacterial endotoxin and the human monoclonal antibody HA-IA: specificity, potential mechanisms of action, and limits to its effectiveness
Innate Immunity, October 1, 1995; 2(5): 371 - 386.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
A.S. Cross and S. Opal
Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?
Innate Immunity, March 1, 1994; 1(1): 57 - 69.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.